Division of Cancer Epidemiology and Genetics

**About DCEG** **One of the world's largest cancer epidemiology research groups** **DCEG Organization** DCEG is organized into branches and laboratories under the [Trans-Divisional Research Program (TDRP)](https://dceg.cancer.gov/about/organization/tdrp). DCEG scientists work closely with the Leidos [Cancer Genomics Research (CGR) Laboratory](https://dceg.cancer.gov/about/organization/programs-hgp/cgr) and is supported by the [Administrative Resources Center](https://dceg.cancer.gov/about/organization/arc). Dr. Chanock's research is housed in the [Laboratory of Genetic Susceptibility](https://dceg.cancer.gov/about/organization/lgs). - **[Biostatistics Branch](https://dceg.cancer.gov/about/organization/tdrp/bb)** Investigators in the Biostatistics Branch develop quantitative methods and tools for cancer research. Meet the branch PIs and fellows, see recent publications, and learn about the branch's priorities. - **[Clinical Genetics Branch](https://dceg.cancer.gov/about/organization/tdrp/cgb)** Investigators in the Clinical Genetics Branch study individuals and populations at high genetic risk of cancer in order to improve our understanding of cancer etiology and to advance clinical care. - **[Infections and Immunoepidemiology Branch](https://dceg.cancer.gov/about/organization/tdrp/iib)** Investigators in the Infections and Immunoepidemiology Branch study infectious agents with established or postulated associations with cancer and immune variation relevant for cancer risk. - **[Integrative Tumor Epidemiology Branch](https://dceg.cancer.gov/about/organization/tdrp/iteb)** Investigators in ITEB investigate cancer etiology and progression through large-scale, integrative analyses of risk factors and tissue profiling to inform prevention and clinical strategies. - **[Laboratory of Translational Genomics](https://dceg.cancer.gov/about/organization/tdrp/ltg)** Investigators in the Laboratory of Translational Genomics study germline and somatic genetics of cancer and conduct analyses on regions of the genome conclusively identified through genome-wide association and family-based studies. - **[Metabolic Epidemiology Branch](https://dceg.cancer.gov/about/organization/tdrp/meb)** Investigators in the Metabolic Epidemiology Branch conduct interdisciplinary research to understand the role of metabolic and lifestyle factors in causing and preventing cancer. - **[Occupational and Environmental Epidemiology Branch](https://dceg.cancer.gov/about/organization/tdrp/oeeb)** Investigators in the Occupational and Environmental Epidemiology Branch conduct studies in the United States and abroad to identify and evaluate environmental and workplace exposures that may be associated with cancer risk. - **[Radiation Epidemiology Branch](https://dceg.cancer.gov/about/organization/tdrp/reb)** Investigators in the Radiation Epidemiology Branch conduct epidemiological, genetic, and radiation dosimetry research to quantify risk, identify susceptible populations, and carry out advanced exposure assessments. **DCEG's Mission** Strategic Plan 2020-2025 DCEG's strategic plan outlines the goals and strategies for achieving its mission of discovering the causes of cancer and the means of its prevention. DCEG's mission is to discover the causes of cancer and inform the means for prevention by conducting transdisciplinary epidemiological and genetic research. DCEG investigators conduct transdisciplinary research on risk factors for cancer, involving extensive trans-divisional, trans-NIH, national and international collaborations. The DCEG research portfolio and vision covers three broad areas: 1. Etiology of cancer 2. Risk prediction, prevention, early detection and clinical outcomes 3. Methodological research on study design and data analytics To achieve its mission, DCEG developed a [strategic plan for 2020-2025](https://dceg.cancer.gov/about/dceg-mission/strategic-plan) with specific goals and strategies. Health disparities and health equity research is a tenet described in the strategic plan. In 2023, discussions for the future of this research in the Division led to to the creation of the [Cancer Health Equity Strategic Goals 2024-2027](https://dceg.cancer.gov/about/dceg-mission/cancer-health-equity-strategic-goals).